Harnessing lymphoma epigenetics to improve therapies is a research paper published in Blood (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA201380
National Institutes of Health
Grant: 5R01CA201380-04
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation
FWCI
0.52
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals